Last edition
News about "paroxysmal supraventricular tachycardia treatment"
Milestone's Etripamil Nasal Spray Wins China NMPA Approval for PSVT
Milestone Pharmaceuticals’ etripamil nasal spray receives China NMPA approval for PSVT, triggering a USD 2 million payment and expanding access in Greater China.
Paroxysmal Supraventricular Tachycardia Treatment | 05/09/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members